Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
SANGAMO THERAPEUTICS, INC [SGMO] posts $192.28M loss as revenue rises 0.54% to $111.30M
By USInMinutes - Mar 04, 2023, 01:54 PM ET
Last Updated - Mar 06, 2023, 12:29 PM EST
Net Sales: | $111.30M |

SANGAMO THERAPEUTICS, INC [SGMO] posted a loss of $192.28M, marking a fall of 7.84% for this year.
Revenue rose to $111.30M this year compared to $110.70M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-192.28M, down 7.84% from $-178.30M.
The company’s net sales for the period were $111.30M, up 0.54%. Net sales in the previous year were $110.70M.
Sponsored
Read More from Investing
Popular News
Latest News